TrialBreast cancer research and treatment2021

Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Noam Pondé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.